Your browser doesn't support javascript.
loading
A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial.
Gennari, A; Sun, Z; Hasler-Strub, U; Colleoni, M; Kennedy, M J; Von Moos, R; Cortés, J; Vidal, M J; Hennessy, B; Walshe, J; Parraga, K Amillano; Ribi, K; Bernhard, J; Murillo, S Morales; Pagani, O; Barbeaux, A; Borstnar, S; Rabaglio-Poretti, M; Maibach, R; Regan, M M; Jerusalem, G.
Afiliação
  • Gennari A; Division of Medical Oncology, E.O. Ospedali Galliera, Genova, Italy. Electronic address: alessandra.gennari@galliera.it.
  • Sun Z; IBCSG Statistical Center, Boston, USA; Frontier Science and Technology Research Foundation, Boston, USA.
  • Hasler-Strub U; Breast Center, Kantonsspital St. Gallen, St. Gallen; SAKK, Bern, Switzerland.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology, Milan, Italy.
  • Kennedy MJ; Department of Medical Oncology, St. James Hospital, Dublin, Ireland.
  • Von Moos R; FMH Medical Oncology, Chur, Switzerland.
  • Cortés J; Department of Medical Oncology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain; Department of Medical Oncology, Ramon y Cajal University Hospital, Barcelona, Spain.
  • Vidal MJ; Breast Cancer & Melanoma Group, Hospital Universitari Vall D'Hebron, Barcelona, Spain.
  • Hennessy B; Centre for Systems Medicine, Beaumont Hospital, Dublin, Ireland.
  • Walshe J; Clinical Trials, Ireland.
  • Parraga KA; Oncology Research Group, Hospital Universitari Sant Joan De Reus, Tarragona, Spain.
  • Ribi K; IBCSG Coordinating Center, Bern, Switzerland.
  • Bernhard J; IBCSG Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland.
  • Murillo SM; Medical Oncology, Hospital Universitari Arnau De Vilanova De Lleida, Lleida, Spain.
  • Pagani O; SAKK, Bern, Switzerland; Breast Unit, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Barbeaux A; Onco-Hematology, CHPLT Verviers, Verviers, Belgium.
  • Borstnar S; Institute of Oncology, Ljubljana, Slovenia.
  • Rabaglio-Poretti M; IBCSG Coordinating Center, Bern, Switzerland; Bern University Hospital, Inselspital, Bern, Switzerland.
  • Maibach R; IBCSG Coordinating Center, Bern, Switzerland.
  • Regan MM; IBCSG Statistical Center, Dana-Farber Cancer Institute, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA.
  • Jerusalem G; Medical Oncology, CHU Sart Tilman, Liege, Belgium.
Ann Oncol ; 29(3): 661-668, 2018 03 01.
Article em En | MEDLINE | ID: mdl-29228091
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Paclitaxel / Albuminas / Quimioterapia de Manutenção / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Paclitaxel / Albuminas / Quimioterapia de Manutenção / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2018 Tipo de documento: Article